10 Mar 2022 Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain Member news
17 Feb 2022 miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study Member news
04 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Member news
25 Jan 2022 Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes Member news
14 Jan 2022 Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women Member news
10 Dec 2021 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Member news
08 Dec 2021 MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis Member news
07 Dec 2021 Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
